Interaction of nanoparticles with immunocompetent cells: nanosafety considerations (Q37970755)

26 August 2017

title

Interaction of nanoparticles with immunocompetent cells: nanosafety considerations (English)

1 reference

26 August 2017

0 references

Luca Costantino

1 reference

26 August 2017

Diana Boraschi

1 reference

26 August 2017

Paola Italiani

series ordinal

1 reference

26 August 2017

language of work or name

1 reference

1 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

page(s)

121-131

1 reference

Immunological risk of injectable drug delivery systems

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Complement: alive and kicking nanomedicines.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Nanocarriers' entry into the cell: relevance to drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Regulated portals of entry into the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Time evolution of the nanoparticle protein corona.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Complement control protein factor H: the good, the bad, and the inadequate.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

NETs: a new strategy for using old weapons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Enzymatic degradation of multiwalled carbon nanotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

To PEGylate or not to PEGylate, that is not the question.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Immunological properties of engineered nanomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Evaluation of nanoparticle immunotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Nanoparticles and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

The suitability of different cellular in vitro immunotoxicity and genotoxicity methods for the analysis of nanoparticle-induced events

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Type I interferon: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

A prescription for human immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Pathogen recognition and development of particulate vaccines: does size matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Particulate vaccines: on the quest for optimal delivery and immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Virus-like particles: passport to immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

The inflammasomes: guardians of the body

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Update on biology: uric acid and the activation of immune and inflammatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

Comparative activity of biodegradable nanoparticles with aluminum adjuvants: Antigen uptake by dendritic cells and induction of immune response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.169

21 January 2018

Identifiers

DOI

10.2217/NNM.11.169

1 reference

26 August 2017

1 reference